Decoding akathisia: The significance of dopamine and dopaminergic pathways - a case report
Authors:
- Mauro Marques LopesMLMauro Marques Lopes
- Gustavo Coutinho Nogueira PereiraGPGustavo Coutinho Nogueira Pereira
- Bruna Carvalho VelosoBVBruna Carvalho Veloso
- Yuri Costa AnjosYAYuri Costa Anjos
- Mariana de Sousa Vilela SilvaMSMariana de Sousa Vilela Silva
- Fabiana AlvesFAFabiana Alves
- Bárbara Faria Corrêa VilelaBVBárbara Faria Corrêa Vilela
- Edmar Geraldo RibeiroEREdmar Geraldo Ribeiro
- Vinícius Corrêa da Silva RochaVRVinícius Corrêa da Silva Rocha
Open Access
- 1 October 2024
- journal article
- Published by Research, Society and Development in Research, Society and Development
- Vol. 13 (10)
Abstract
Background: Dopamine and dopaminergic pathways are crucial in antipsychotic treatment and the emergence of akathisia. Understanding these mechanisms is essential for effectively managing this condition. Objective: This study aims to highlight the management of akathisia in a patient with schizophrenia while underscoring the significance of dopaminergic mechanisms in treatment. Methods: Following the CARE (CAse REports) guidelines, this study presents a case report that serves as a practical representation of clinical scenarios, contextualizing theoretical concepts through real-world examples, enhancing the understanding of rare conditions and unique treatment responses. Case Report and Discussion: A 59-year-old female patient diagnosed with schizophrenia developed severe akathisia after starting risperidone. She exhibited intense restlessness and emotional distress, requiring adjustments to her treatment regimen, including the addition of propranolol, clonazepam, and phenytoin. This case illustrates the intricate relationship between dopamine dysregulation and akathisia, emphasizing the necessity for personalized treatment strategies tailored to the patient's needs. It highlights the importance of close monitoring and flexible management in addressing adverse effects associated with antipsychotic medications. Furthermore, fostering a supportive therapeutic relationship with the mental health team and incorporating familial support significantly contributed to the patient's overall treatment success. Conclusion: Understanding dopaminergic pathways is vital for managing akathisia and schizophrenia. This study advocates for a holistic treatment approach that integrates clinical insights with psychosocial factors to improve the patient's quality of life and treatment adherence.Keywords
This publication has 13 references indexed in Scilit:
- Acetaminophen improves tardive akathisia induced by dopamine D2 receptor antagonistsJournal of Pharmacological Sciences, 2022
- Amisulpride withdrawal akathisia responding to aripiprazole with propranolol in first-onset psychosis: a case reportBMC Psychiatry, 2022
- Antipsychotic-induced extrapyramidal side effects: A systematic review and meta-analysis of observational studiesPLOS ONE, 2021
- Movement disorders induced by psychiatric drugs that do not block dopamine receptorsParkinsonism & Related Disorders, 2020
- Treatment of Antipsychotic-Induced Akathisia: Role of Serotonin 5-HT2a Receptor AntagonistsDrugs, 2020
- Characteristics of Patients Experiencing Extrapyramidal Symptoms or Other Movement Disorders Related to Dopamine Receptor Blocking Agent TherapyJournal of Clinical Psychopharmacology, 2019
- Medication-Induced Akathisia with Newly Approved Antipsychotics in Patients with a Severe Mental Illness: A Systematic Review and Meta-AnalysisCNS Drugs, 2019
- The psychopharmacology of catatonia, neuroleptic malignant syndrome, akathisia, tardive dyskinesia, and dystonia2019
- CARE guidelines for case reports: explanation and elaboration documentJournal of Clinical Epidemiology, 2017
- Tips for writing a case report for the novice authorJournal of Medical Radiation Sciences, 2013